Year-over-year articles
ACD PHARMACEUTICALS AS
29 crawlable comparisons of consecutive annual reports.
Full company analysis · Org.nr 979 455 518
Weaker earnings, fresh owner capital
Comparing Årsregnskap 2025 with 2024 for ACD PHARMACEUTICALS AS. Revenue 24.67m NOK → 25.63m NOK (+3.9%). Net result -967.1k NOK → -1.92m NOK.
Shrank 16% on revenue, slipped into loss, cash halved-plus
Comparing Årsregnskap 2024 with 2023 for ACD PHARMACEUTICALS AS. Revenue 29.42m NOK → 24.67m NOK (-16.2%). Net result +3.65m NOK → -967.1k NOK.
Grew 10% on revenue, returned to profit, cash halved-plus
Comparing Årsregnskap 2023 with 2022 for ACD PHARMACEUTICALS AS. Revenue 26.85m NOK → 29.42m NOK (+9.6%). Net result -12.27m NOK → +3.65m NOK.
Grew 111% on revenue, slipped into loss, cash halved-plus
Comparing Årsregnskap 2022 with 2021 for ACD PHARMACEUTICALS AS. Revenue 12.71m NOK → 26.85m NOK (+111.3%). Net result +1.14m NOK → -12.27m NOK. Equity…
Shrank 26% on revenue, weaker earnings
Comparing Årsregnskap 2021 with 2020 for ACD PHARMACEUTICALS AS. Revenue 17.08m NOK → 12.71m NOK (-25.6%). Net result +9.12m NOK → +1.14m NOK. Equity 11.89m…
Shrank 15% on revenue
Comparing Årsregnskap 2020 with 2019 for ACD PHARMACEUTICALS AS. Revenue 20.03m NOK → 17.08m NOK (-14.7%). Net result +10.44m NOK → +9.12m NOK. Equity 2.77m…
A steady year on the published lines
Comparing Årsregnskap 2019 with 2018 for ACD PHARMACEUTICALS AS. Revenue 19.46m NOK → 20.03m NOK (+2.9%). Equity 2.34m NOK → 2.77m NOK.
Grew 61% on revenue
Comparing Årsregnskap 2018 with 2017 for ACD PHARMACEUTICALS AS. Revenue 12.06m NOK → 19.46m NOK (+61.4%). Equity 2.20m NOK → 2.34m NOK.
Grew 60% on revenue, returned to profit
Comparing Årsregnskap 2017 with 2016 for ACD PHARMACEUTICALS AS. Revenue 7.56m NOK → 12.06m NOK (+59.5%). Net result -306.1k NOK → +480.5k NOK. Equity 6.71m…
Grew 24% on revenue, stronger earnings, fresh owner capital
Comparing Årsregnskap 2016 with 2015 for ACD PHARMACEUTICALS AS. Revenue 6.08m NOK → 7.56m NOK (+24.3%). Net result -598.3k NOK → -306.1k NOK. Equity 5.91m…
Slipped into loss, fresh owner capital
Comparing Årsregnskap 2015 with 2014 for ACD PHARMACEUTICALS AS. Revenue 6.32m NOK → 6.08m NOK (-3.8%). Net result +319.2k NOK → -598.3k NOK. Equity 5.14m…
Shrank 24% on revenue
Comparing Årsregnskap 2014 with 2013 for ACD PHARMACEUTICALS AS. Revenue 8.31m NOK → 6.32m NOK (-24.0%). Equity 3.95m NOK → 5.14m NOK.
Grew 7% on revenue
Comparing Årsregnskap 2013 with 2012 for ACD PHARMACEUTICALS AS. Revenue 7.75m NOK → 8.31m NOK (+7.2%). Equity 5.05m NOK → 3.95m NOK.
Shrank 62% on revenue
Comparing Årsregnskap 2012 with 2011 for ACD PHARMACEUTICALS AS. Revenue 20.22m NOK → 7.75m NOK (-61.7%). Equity 3.44m NOK → 5.05m NOK.
Grew 30% on revenue
Comparing Årsregnskap 2011 with 2010 for ACD PHARMACEUTICALS AS. Revenue 15.58m NOK → 20.22m NOK (+29.8%). Equity 92.9k NOK → 3.44m NOK.
Grew 31% on revenue
Comparing Årsregnskap 2010 with 2009 for ACD PHARMACEUTICALS AS. Revenue 11.87m NOK → 15.58m NOK (+31.2%). Equity 839.0k NOK → 92.9k NOK.
Grew 65% on revenue
Comparing Årsregnskap 2009 with 2008 for ACD PHARMACEUTICALS AS. Revenue 7.20m NOK → 11.87m NOK (+64.9%). Equity 721.1k NOK → 839.0k NOK.
Grew 8% on revenue
Comparing Årsregnskap 2008 with 2007 for ACD PHARMACEUTICALS AS. Revenue 6.64m NOK → 7.20m NOK (+8.4%). Equity 752.5k NOK → 721.1k NOK.
Grew 185% on revenue, stronger earnings
Comparing Årsregnskap 2007 with 2006 for ACD PHARMACEUTICALS AS. Revenue 2.33m NOK → 6.64m NOK (+184.8%). Net result +265.4k NOK → +394.4k NOK. Equity…
Grew 80% on revenue, returned to profit
Comparing Årsregnskap 2006 with 2005 for ACD PHARMACEUTICALS AS. Revenue 1.30m NOK → 2.33m NOK (+79.5%). Net result -71.2k NOK → +265.4k NOK. Equity 293.5k…
Shrank 21% on revenue, slipped into loss
Comparing Årsregnskap 2005 with 2004 for ACD PHARMACEUTICALS AS. Revenue 1.65m NOK → 1.30m NOK (-21.1%). Net result +484.1k NOK → -71.2k NOK. Equity 364.7k…
Grew 31% on revenue, weaker earnings
Comparing Årsregnskap 2004 with 2003 for ACD PHARMACEUTICALS AS. Revenue 1.26m NOK → 1.65m NOK (+30.6%). Net result +11.46m NOK → +484.1k NOK. Equity 355.3k…
Stronger earnings
Comparing Årsregnskap 2003 with 2002 for ACD PHARMACEUTICALS AS. Revenue 1.28m NOK → 1.26m NOK (-1.9%). Net result +379.5k NOK → +11.46m NOK. Equity 382.7k…
Grew 492% on revenue, stronger earnings, cash halved-plus
Comparing Årsregnskap 2002 with 2001 for ACD PHARMACEUTICALS AS. Revenue 217.0k NOK → 1.28m NOK (+491.9%). Net result +5 119 NOK → +379.5k NOK. Equity…
Shrank 77% on revenue, weaker earnings, cash halved-plus
Comparing Årsregnskap 2001 with 2000 for ACD PHARMACEUTICALS AS. Revenue 953.0k NOK → 217.0k NOK (-77.2%). Net result +17.1k NOK → +5 119 NOK.
Grew 93% on revenue
Comparing Årsregnskap 2000 with 1999 for ACD PHARMACEUTICALS AS. Revenue 495.0k NOK → 953.0k NOK (+92.5%).
Shrank 88% on revenue
Comparing Årsregnskap 1999 with 1998 for ACD PHARMACEUTICALS AS. Revenue 4.00m NOK → 495.0k NOK (-87.6%). Equity 298.1k NOK → 315.2k NOK.
Mixed movements in the accounts
Comparing Årsregnskap 1998 with 1997 for ACD PHARMACEUTICALS AS. Equity 685.39bn NOK → 298.1k NOK.
First published accounts
First year in the published series for ACD PHARMACEUTICALS AS (1997). No prior-year comparative in this dataset.